Rare diseases
Investigational molecules
Locations
Calle De Mateo Inurria 30, 28036 Madrid, Spain
Research activity includes apixaban formulations, with interest in anticoagulation and the prevention of thromboembolic events.
The sponsor’s clinical work in this area is centered on oral antithrombotic medicines and their therapeutic equivalence.
Alter Farmacia S.A. runs clinical trials in conditions such as Embolism, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
